Allgemeine Epileptologie. Группа авторов

      Elisak M, Krysl D, Hanzalova J, Volna K, Bien CG, Leypoldt F, Marusic P (2018) The prevalence of neural antibodies in temporal lobe epilepsy and the clinical characteristics of seropositive patients. Seizure 63:1-6

      Finke C, Prüss H, Heine J, Reuter S, Kopp UA, Wegner F, Then Bergh F, Koch S, Jansen O, Münte T, Deuschl G, Ruprecht K, Stöcker W, Wandinger KP, Paul F, Bartsch T (2017) Evaluation of Cognitive Deficits and Structural Hippocampal Damage in Encephalitis With Leucine-Rich, Glioma-Inactivated 1 Antibodies. JAMA Neurol 74:50-59

      Fisher RS, Acevedo C, Arzimanoglou A, Bogacz A, Cross JH, Elger CE, Engel J, Jr., Forsgren L, French JA, Glynn M, Hesdorffer DC, Lee BI, Mathern GW, Moshe SL, Perucca E, Scheffer IE, Tomson T, Watanabe M, Wiebe S (2014) ILAE official report: a practical clinical definition of epilepsy. Epilepsia 55:475-482

      Gaspard N, Foreman BP, Alvarez V, Cabrera Kang C, Probasco JC, Jongeling AC, Meyers E, Espinera A, Haas KF, Schmitt SE, Gerard EE, Gofton T, Kaplan PW, Lee JW, Legros B, Szaflarski JP, Westover BM, LaRoche SM, Hirsch LJ (2015) New-onset refractory status epilepticus: Etiology, clinical features, and outcome. Neurology 85:1604-1613

      Geis C, Planaguma J, Carreno M, Graus F, Dalmau J (2019) Autoimmune seizures and epilepsy. J Clin Invest 129:926-940

      Graus F, Delattre JY, Antoine JC, Dalmau J, Giometto B, Grisold W, Honnorat J, Sillevis Smitt P, Vedeler C, Verschuuren JJ, Vincent A, Voltz R (2004) Recommended diagnostic criteria for paraneoplastic neurological syndromes. J Neurol Neurosurg Psychiatry 75:1135-1140

      Graus F, Titulaer MJ, Balu R, Benseler S, Bien CG, Cellucci T, Cortese I, Dale RC, Gelfand JM, Geschwind M, Glaser CA, Honnorat J, Hoftberger R, Iizuka T, Irani SR, Lancaster E, Leypoldt F, Pruss H, Rae-Grant A, Reindl M, Rosenfeld MR, Rostasy K, Saiz A, Venkatesan A, Vincent A, Wandinger KP, Waters P, Dalmau J (2016) A clinical approach to diagnosis of autoimmune encephalitis. Lancet Neurol 15:391-404

      Hughes EG, Peng X, Gleichman AJ, Lai M, Zhou L, Tsou R, Parsons TD, Lynch DR, Dalmau J, Balice-Gordon RJ (2010) Cellular and synaptic mechanisms of anti-NMDA receptor encephalitis. J Neurosci 30:5866-5875

      Irani SR, Bien CG, Lang B (2011) Autoimmune epilepsies. Curr Opin Neurol 24:146-153

      Körtvelyessy P, Bauer J, Stoppel CM, Bruck W, Gerth I, Vielhaber S, Wiedemann FR, Heinze HJ, Bartels C, Bien CG (2015) Complement-associated neuronal loss in a patient with CASPR2 antibody-associated encephalitis. Neurol Neuroimmunol Neuroinflamm 2:e75

      Lee WJ, Lee ST, Byun JI, Sunwoo JS, Kim TJ, Lim JA, Moon J, Lee HS, Shin YW, Lee KJ, Kim S, Jung KH, Jung KY, Chu K, Lee SK (2016) Rituximab treatment for autoimmune limbic encephalitis in an institutional cohort. Neurology 86:1683-1691

      Liu X, Yan B, Wang R, Li C, Chen C, Zhou D, Hong Z (2017) Seizure outcomes in patients with anti-NMDAR encephalitis: A follow-up study. Epilepsia 58:2104-2111

      Malter MP, Frisch C, Schoene-Bake JC, Helmstaedter C, Wandinger KP, Stoecker W, Urbach H, Surges R, Elger CE, Vincent AV, Bien CG (2014) Outcome of limbic encephalitis with VGKC-complex antibodies: relation to antigenic specificity. J Neurol 261:1695-1705

      Malter MP, Frisch C, Zeitler H, Surges R, Urbach H, Helmstaedter C, Elger CE, Bien CG (2015) Treatment of immune-mediated temporal lobe epilepsy with GAD antibodies. Seizure 30:57-63

      Nóbrega-Jr AW, Gregory CP, Schlindwein-Zanini R, Neves FS, Wolf P, Walz R, Steindel M, Lin K (2018) Mesial temporal lobe epilepsy with hippocampal sclerosis is infrequently associated with neuronal autoantibodies. Epilepsia 59:e152-e156

      Ohkawa T, Fukata Y, Yamasaki M, Miyazaki T, Yokoi N, Takashima H, Watanabe M, Watanabe O, Fukata M (2013) Autoantibodies to epilepsy-related LGI1 in limbic encephalitis neutralize LGI1-ADAM22 interaction and reduce synaptic AMPA receptors. J Neurosci 33:18161-18174

      Olson HE, Lechpammer M, Prabhu SP, Ciarlini PD, Poduri A, Gooty VD, Anjum MW, Gorman MP, Loddenkemper T (2013) Clinical application and evaluation of the Bien diagnostic criteria for Rasmussen encephalitis. Epilepsia 54:1753-1760

      Peng X, Hughes EG, Moscato EH, Parsons TD, Dalmau J, Balice-Gordon RJ (2015) Cellular plasticity induced by anti-alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA) receptor encephalitis antibodies. Ann Neurol 77:381-398

      Petit-Pedrol M, Sell J, Planagumà J, Mannara F, Radosevic M, Haselmann H, Ceanga M, Sabater L, Spatola M, Soto D (2018) LGI1 antibodies alter Kv1. 1 and AMPA receptors changing synaptic excitability, plasticity and memory. Brain 141:3144-3159

      Poepel A, Jarius S, Heukamp LC, Urbach H, Elger CE, Bien CG, Voltz R (2007) Neurological course of long-term surviving patients with SCLC and anti-Hu syndrome. J Neurol Sci 263:145-148

      Steriade C, Britton J, Dale RC, Gadoth A, Irani SR, Linnoila J, McKeon A, Shao XQ, Venegas V, Bien CG (2020) Acute symptomatic seizures secondary to autoimmune encephalitis and autoimmune-associated epilepsy: Conceptual definitions. Epilepsia 61:1341-1351.

      Thompson J, Bi M, Murchison AG, Makuch M, Bien CG, Chu K, Farooque P, Gelfand JM, Geschwind MD, Hirsch LJ, Somerville E, Lang B, Vincent A, Leite MI, Waters P, Irani SR (2018) The importance of early immunotherapy in patients with faciobrachial dystonic seizures. Brain 141:348-356

      Titulaer MJ, McCracken L, Gabilondo I, Armangue T, Glaser C, Iizuka T, Honig LS, Benseler SM, Kawachi I, Martinez-Hernandez E, Aguilar E, Gresa-Arribas N, Ryan-Florance N, Torrents A, Saiz A, Rosenfeld MR, Balice-Gordon R, Graus F, Dalmau J (2013) Treatment and prognostic factors for long-term outcome in patients with anti-NMDA receptor encephalitis: an observational cohort study. Lancet Neurol 12:157-165

      Tröscher AR, Wimmer I, Quemada-Garrido L, Köck U, Gessl D, Verberk SGS, Martin B, Lassmann H, Bien CG, Bauer J (2019) Microglial nodules provide the environment for pathogenic T cells in human encephalitis. Acta Neuropathol 137:619-635